Development of a novel split, frozen, thawed and washed red cell component for intrauterine transfusion
Vox Sanguinis · 2026-06 · 121 (6) · 809-813
DOI: 10.1111/vox.70244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vox Sanguinis, online erschienen am 12.03.2026. Verfasst von Athinoula Meli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Component Development Laboratory, NHS Blood and Transplant, Cambridge, UK. Hauptthemen laut MEDLINE: Blood Transfusion, Intrauterine, Erythrocytes, Cryopreservation, Blood Preservation. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Background and Objectives Provision of red cells for intrauterine transfusion (IUT) can be challenging when the mother has an antibody to a high frequency antigen, as compatible allogeneic red cells may be scarce. The aim was to validate a novel component: split, frozen, thawed, washed and irradiated red cells for IUT, which could be used if foetal transfusion with maternal blood is necessary. Materials and Methods Six standard red cell concentrates were glycerolized on Day 5 and split into three smaller packs before freezing. A split from each donation was thawed and deglycerolized using the ACP215 and resuspended in saline‐adenine‐glucose‐mannitol. The haematocrit was adjusted to IUT (70%–85%). The components, each approximately 80 mL, were immediately irradiated and tested for full blood count, haemolysis and supernatant potassium 8 and 24 h later.
Results
At 8 and 24 h post manufacture, haemolysis was 0.20% (0.16%–0.25%) and 0.24% (0.18%–0.29%), respectively, and supernatant potassium was 20.3 mmol/L (15.1–27.1 mmol/L) and 43.1 mmol/L (33.5–58.4 mmol/L), respectively (mean [range]). Both haemolysis and potassium were within levels for standard irradiated IUT units.
Conclusion
Red cells split, frozen, thawed, washed and manufactured into IUT units and immediately irradiated are expected to be a beneficial component for very rare clinical cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Component Development Laboratory, NHS Blood and Transplant, Cambridge, UK.
- National Frozen Blood Bank, NHS Blood and Transplant, Liverpool, UK.
- International Blood Group Reference Laboratory, NHS Blood and Transplant, Bristol, UK.
- Clinical Directorate, NHS Blood and Transplant, London, UK.
- Clinical Directorate, NHS Blood and Transplant, Birmingham, UK.
- Clinical Directorate, NHS Blood and Transplant, Filton, UK.
ORCID-Profile: Athinoula Meli, Suzy Morton
Zitieren
APA
Meli, A., Healy, D., Howarth, G., Grimsley, S., New, H. V., Morton, S., & Paulus, U. (2026). Development of a novel split, frozen, thawed and washed red cell component for intrauterine transfusion. Vox Sanguinis, 121(6), 809-813. https://doi.org/10.1111/vox.70244
Vancouver
Meli A, Healy D, Howarth G, Grimsley S, New HV, Morton S, et al. Development of a novel split, frozen, thawed and washed red cell component for intrauterine transfusion. Vox Sanguinis. 2026;121(6):809-813. doi:10.1111/vox.70244
BibTeX
@article{Meli2026,
author = {Meli, Athinoula and Healy, David and Howarth, Gina and Grimsley, Shane and New, Helen V and Morton, Suzy and Paulus, Ulrike},
title = {Development of a novel split, frozen, thawed and washed red cell component for intrauterine transfusion},
journal = {Vox Sanguinis},
year = {2026},
volume = {121},
number = {6},
pages = {809--813},
doi = {10.1111/vox.70244}
}
EUVIMED